Literature DB >> 15993501

A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.

Michiel Rienstra1, Isabelle C Van Gelder, Maarten P Van den Berg, Frans Boomsma, Hans L Hillege, Dirk J Van Veldhuisen.   

Abstract

BACKGROUND: Atrial fibrillation is common in chronic heart failure. Long-term restoration of sinus rhythm is generally unsuccessful. It may be speculated that higher heart rates are unfavorable, since this may lead to tachycardiomyopathy, but there are no data which have examined this. METHODS AND
RESULTS: Seventy-seven patients with atrial fibrillation and advanced chronic heart failure, age 70 +/- 7 years, left-ventricular ejection fraction 0.23 +/- 0.08, 61% with ischemic etiology were included. Patients were dichotomized according to the median heart rate (80 bpm) at inclusion (39 patients with "low" heart rate and 38 patients with "high" heart rate). At baseline, both patient groups were remarkably comparable. After a mean follow-up of 3.3 +/- 0.9 years, mortality was comparable (62% versus 55%, p = non-significant). An independent relation was found between lower heart rate and survival, in addition to absence of hypertension, digoxin use, and higher N-ANP, dopamine, and renin levels.
CONCLUSION: In the present analysis, patients with atrial fibrillation and advanced chronic heart failure with higher heart rates are comparable to those with lower heart rates. Not higher heart rates at baseline but, on the contrary, lower heart rates seem associated with a worse outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993501     DOI: 10.1016/j.ijcard.2005.05.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Virginia Mplani; Maria Anastasopoulou; Nicholas Kounis; Cesare de Gregorio; Grigorios Tsigkas; Arun Karunakaran; Panagiotis Plotas; Ignatios Ikonomidis
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

2.  Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.

Authors:  Bart A Mulder; Kevin Damman; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Michiel Rienstra
Journal:  Clin Cardiol       Date:  2017-05-17       Impact factor: 2.882

Review 3.  Atrial fibrillation in heart failure: current treatment of patients with remodeled atria.

Authors:  Hans-Ruprecht Neuberger; Jan-Christian Reil; Oliver Adam; Ulrich Laufs; Christian Mewis; Michael Böhm
Journal:  Curr Heart Fail Rep       Date:  2008-12

Review 4.  Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.

Authors:  Rafik Tadros; Paul Khairy; Jean L Rouleau; Mario Talajic; Peter G Guerra; Denis Roy
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

5.  Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.

Authors:  Athanasius Wrin Hudoyo; Hiroki Fukuda; Miki Imazu; Kazuhiro Shindo; Haiying Fu; Yuko Iwata; Shin Ito; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2019-06-18       Impact factor: 3.872

6.  The prognostic effects of ventricular heart rate among patients with permanent atrial fibrillation with and without coronary artery disease: a multicenter prospective observational study.

Authors:  Huaibin Wan; Yanmin Yang; Jun Zhu; Xinghui Shao; Juan Wang; Bi Huang; Han Zhang
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

7.  β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.

Authors:  Jin Joo Park; Hyun-Ah Park; Hyun-Jai Cho; Hae-Young Lee; Kye Hun Kim; Byung-Su Yoo; Seok-Min Kang; Sang Hong Baek; Eun-Seok Jeon; Jae-Joong Kim; Myeong-Chan Cho; Shung Chull Chae; Byung-Hee Oh; Dong-Ju Choi
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

Review 8.  Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week.

Authors:  Alexander C Fanaroff; Robert M Califf; Robert A Harrington; Christopher B Granger; John J V McMurray; Manesh R Patel; Deepak L Bhatt; Stephan Windecker; Adrian F Hernandez; C Michael Gibson; John H Alexander; Renato D Lopes
Journal:  J Am Coll Cardiol       Date:  2020-08-04       Impact factor: 24.094

9.  Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Authors:  Emmanouil Chourdakis; Ioanna Koniari; Dimitrios Velissaris; Grigorios Tsigkas; Nikolaos G Kounis; Neriman Osman
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

Review 10.  Update on management of atrial fibrillation in heart failure: a focus on ablation.

Authors:  Bart A Mulder; Michiel Rienstra; Isabelle C Van Gelder; Yuri Blaauw
Journal:  Heart       Date:  2021-06-04       Impact factor: 5.994

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.